The Clorox Company (NYSE:CLX) Stake Reduced by Toronto Dominion Bank

Toronto Dominion Bank trimmed its stake in The Clorox Company (NYSE:CLX) by 13.6% during the second quarter, according to its most recent disclosure with the SEC. The fund owned 60,693 shares of the company’s stock after selling 9,525 shares during the quarter. Toronto Dominion Bank’s holdings in Clorox were worth $8,283,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of the company. Core Wealth Advisors Inc. bought a new stake in Clorox in the 4th quarter valued at about $29,000. Innealta Capital LLC acquired a new position in shares of Clorox during the second quarter worth approximately $30,000. Trifecta Capital Advisors LLC grew its holdings in Clorox by 139.8% in the 2nd quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock worth $30,000 after buying an additional 130 shares in the last quarter. GoalVest Advisory LLC acquired a new stake in Clorox in the 1st quarter valued at approximately $31,000. Finally, First Foundation Advisors bought a new stake in Clorox during the 1st quarter valued at $31,000. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Price Performance

NYSE CLX opened at $163.42 on Friday. The Clorox Company has a 1 year low of $114.68 and a 1 year high of $169.09. The stock’s 50-day moving average price is $151.92 and its two-hundred day moving average price is $144.14. The company has a market cap of $20.29 billion, a PE ratio of 84.67, a PEG ratio of 3.31 and a beta of 0.40. The company has a current ratio of 1.03, a quick ratio of 0.63 and a debt-to-equity ratio of 5.04.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Thursday, August 1st. The company reported $1.82 EPS for the quarter, beating the consensus estimate of $1.54 by $0.28. Clorox had a net margin of 3.95% and a return on equity of 281.12%. The business had revenue of $1.90 billion during the quarter, compared to the consensus estimate of $1.97 billion. On average, analysts predict that The Clorox Company will post 6.63 EPS for the current year.

Clorox Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd will be issued a dividend of $1.22 per share. The ex-dividend date is Wednesday, October 23rd. This represents a $4.88 dividend on an annualized basis and a dividend yield of 2.99%. Clorox’s dividend payout ratio is 252.85%.

Insider Activity at Clorox

In other news, EVP Angela C. Hilt sold 1,733 shares of the company’s stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $165.52, for a total value of $286,846.16. Following the transaction, the executive vice president now owns 13,471 shares in the company, valued at approximately $2,229,719.92. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 0.51% of the stock is owned by insiders.

Analyst Ratings Changes

A number of brokerages have recently commented on CLX. TD Cowen initiated coverage on Clorox in a report on Tuesday, July 23rd. They set a “sell” rating and a $122.00 price target on the stock. Deutsche Bank Aktiengesellschaft raised their target price on shares of Clorox from $144.00 to $151.00 and gave the company a “hold” rating in a research note on Friday, August 2nd. Citigroup upped their price target on shares of Clorox from $165.00 to $170.00 and gave the stock a “neutral” rating in a research note on Friday, September 6th. BNP Paribas upgraded shares of Clorox to a “strong sell” rating in a research note on Friday, September 6th. Finally, DA Davidson restated a “neutral” rating and issued a $153.00 target price on shares of Clorox in a research report on Friday, September 6th. Six research analysts have rated the stock with a sell rating and twelve have assigned a hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $143.33.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.